Gedeon Richter (www.richter.hu), headquartered in Budapest, Hungary, founded in 1901 is a major pharmaceutical company in Central Eastern Europe, with an expanding direct presence in Western Europe and Latin America.

Gedeon Richter has manufacturing and R&D sites in Hungary, Romania, Poland, India, Germany, Switzerland, Ukraine and in Russia. The company has direct presence in more than 40 countries. The company currently manufactures about 100 pharmaceutical products in more than 170 presentations. The products of the company are available in more than 100 countries around the World.

Richter’s consolidated sales were approximately EUR1.2 billion (US$1.6 billion) while its market capitalization amounted to EUR2.8 billion (US$3.8 billion) in 2013.
The product portfolio of Richter covers almost all important therapeutic areas, including gynaecology, central nervous system and cardiovascular areas.

Having largest R&D unit in Central Eastern Europe, Richter’ original research activity focuses on CNS disorders. With its widely acknowledged steroid chemistry expertise, Richter is a significant player in the female healthcare field worldwide. Richter is also active in biosimilar product development.

From 1954, the drugs of Gedeon Richter Plc are available in Vietnam. Since 1995 Gedeon Richter Plc. is represented in Vietnam directly. The company has 100 Vietnamese employees and 2 expatriate representatives, Representative offices in Hanoi and Saigon. Our current activities are focusing on gynaecology, neurology, and cardio-vascular field.